Pediatric cancer survivorship: Research and clinical care

Journal of Clinical Oncology

Volumn 24, Issue 32, 2006, Pages 5160-5165

  Meadows, Anna T ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE;

AGE DISTRIBUTION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CHILDHOOD CANCER; CLINICAL TRIAL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; HEALTH CARE; HEALTH CARE SYSTEM; HEALTH PROGRAM; HODGKIN DISEASE; HUMAN; LEUKEMIA; NEPHROBLASTOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHABDOMYOSARCOMA; SURVIVAL RATE; UNITED STATES; ADOLESCENT; ADULT; AFTERCARE; CHILD; HEALTH CARE QUALITY; METHODOLOGY; NEOPLASM; ONCOLOGY; PATIENT CARE; PEDIATRICS; RESEARCH; SURVIVOR;

ADOLESCENT; ADULT; AFTERCARE; CHILD; CONTINUITY OF PATIENT CARE; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PATIENT CARE TEAM; PEDIATRICS; QUALITY OF HEALTH CARE; QUALITY OF LIFE; RESEARCH; SURVIVORS;

EID: 34247181677     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.07.3114     Document Type: Review

References (68)

1. Hewitt M, Weiner SL, Simone JV: Childhood Cancer Survivorship: Improving Care and Quality of Life. Washington, DC, National Academy Press, 2003
2. Hewitt M, Greenfield S, Stovall E: Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC, National Academy Press, 2005
3. Farber S: Chemotherapy in the treatment of leukemia and Wilms' tumor. JAMA 198:826-836, 1966
4. Simone J, Aur RJ, Hustu HO, et al: "Total therapy" studies of acute lymphocytic leukemia in children: Current results and prospects for cure. Cancer 30:1488-1494, 1972
5. Wilbur JR: Combination chemotherapy for embryonal rhabdomyosarcoma. Cancer Chemother Rep 58:281-284, 1974
6. Meadows AT, D'Angio GJ: Late effects of cancer treatment: Methods and techniques for detection. Semin Oncol 1:87-90, 1974
7. Meadows AT, D'Angio GJ, Evans AE, et al: Oncogenesis and other late effects of cancer treatment in children. Radiology 114:175-180, 1975
8. Meadows AT, Krejmas NL, Belasco JB, for the Late Effects Study Group: The medical cost of cure: Sequelae in survivors of childhood cancer, in van Eys J, Sullivan MP(eds): Status of the Curability of Childhood Cancers. New York, NY, Raven Press, 1980, pp 263-276
9. Meadows AT, D'Angio GJ, Mike V, et al: Patterns of second malignant neoplasms in children. Cancer 40:1903-1911, 1977
10. Mike V, Meadows AT, D'Angio GJ: Incidence of second malignant neoplasms in children: Results of an international study. Lancet 2:1326-1331, 1982
11. Meadows AT, Baum E, Fossati-Bellani F, et al: Second malignant neoplasms in children: An update from the Late Effects Study Group. J Clin Oncol 3:532-538, 1985
12. Tucker MA, Meadows AT, Boice JD, et al: Cancer risk following treatment of childhood cancer, in Fraumeni JF, Boice JD (eds): Radiation Carcinogenesis: Epidemiology and Biological Significance. New York, NY, Raven Press, 1984, pp 211-224
13. Tucker MA, Meadows AT, Boice JD Jr, et al: Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 78:459-464, 1987
14. Tucker MA, D'Angio GJ, Boice JD, et al: Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 317:588-593, 1987
15. Tucker MA, Jones PH, Boice JD Jr, et al: Therapeutic radiation at a young age is linked to secondary thyroid cancer: The Late Effects Study Group. Cancer Res 51:2885-2888, 1991
16. Kingston JE, Hawkins MM, Draper GJ, et al: Patterns of multiple primary tumours in patients treated for cancer during childhood. Br J Cancer 56:331-338, 1987
17. Neglia JP, Meadows AT, Robison LL, et al: Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 325:1330-1336, 1991
18. Olsen JH, Garwicz S, Hertz H, et al: Second malignant neoplasms after cancer in childhood or adolescence: Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. BMJ 307:1030-1036, 1993
19. Heyn R, Haeberlen V, Newton WA, et al: Second malignant neoplasms in children treated for rhabdomyosarcoma: Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol 11:262-270, 1993
20. Breslow NE, Takashima JR, Whitton JA, et al: Second malignant neoplasms following treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 13:1851-1859, 1995
21. Sankila R, Garwicz S, Olsen JH, et al: Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries - Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology. J Clin Oncol 14:1442-1446, 1996
22. Travis LB, Curtis RE, Boice JD Jr, et al: Second malignant neoplasms among long-term survivors of ovarian cancer. Cancer Res 56:1564-1570, 1996
23. Swerdlow AJ, Barber JA, Hudson GV, et al: Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J Clin Oncol 18:498-509, 2000
24. van Leeuwen FE, Klokman WJ, Veer MB, et al: Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18:487-497, 2000
25. Metayer C, Lynch CF, Clarke EA, et al: Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18:2435-2443, 2000
26. Meadows AT, Obringer AC, Marrero O, et al: Second malignant neoplasms following childhood Hodgkin's disease: Treatment and splenectomy as risk factors. Med Pediatr Oncol 17:477-484, 1989
27. Bhatia S, Robison LL, Oberlin O, et al: Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745-751, 1996
28. Bhatia S, Yasui Y, Robison LL, et al: High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the Late Effects Study Group. J Clin Oncol 21:4386-4394, 2003
29. Walter AW, Hancock ML, Pui CH, et al: Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. J Clin Oncol 16:3761-3767, 1998
30. Loning L, Zimmermann M, Reiter A, et al: Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: Significantly lower risk without cranial radiotherapy. Blood 95:2770-2775, 2000
31. Kleinerman RA, Tucker MA, Tarone RE, et al: Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: An extended follow-up. J Clin Oncol 23:2272-2279, 2005
32. Rheingold SR, Neugut AI, Meadows AT: Treatment-related secondary cancers. Holland J, Frei E III, Bast RC, et al (eds): Cancer Medicine (ed 7). Hamilton, Ontario, Canada, BC Decker Inc, 2006, pp 2216-2221
33. Shalet SM, Beardwell CG: Endocrine consequences of treatment of malignant disease in childhood: A review. J R Soc Med 72:39-41, 1979
34. Meadows AT, Gordon J, Massan DJ, et al: Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukaemia treated with cranial irradiation. Lancet 2:1015-1018, 1981
35. Rowland JH, Glidewell OJ, Sibley RF, et al: Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia. J Clin Oncol 2:1327-1335, 1984
36. Hamre MR, Robison LL, Nesbit ME, et al: Effects of radiation on ovarian function in long-term survivors of childhood acute lymphoblastic leukemia: A report from the Children's Cancer Study Group. J Clin Oncol 5:1759-1765, 1987
37. Silber JH, Littman PS, Meadows AT: Stature loss following skeletal irradiation for childhood cancer. J Clin Oncol 8:304-312, 1990
38. Mulhern RK, Fairclough D, Ochs J: A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation. J Clin Oncol 9:1348-1356, 1991
39. Copeland DR, Moore BD III, Francis DJ, et al: Neuropsychologic effects of chemotherapy on children with cancer: A longitudinal study. J Clin Oncol 14:2826-2835, 1996
40. Robison LL, Nesbit ME Jr, Sather HN, et al: Factors associated with IQ scores in long-term survivors of childhood acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 6:115-121, 1984
41. Silber JH, Radcliffe J, Peckham V, et al: Whole-brain irradiation and decline in intelligence: The influence of dose and age on IQ score. J Clin Oncol 10:1390-1396, 1992
42. Ritchey ML, Green DM, Thomas PR, et al: Renal failure in Wilms' tumor patients: A report from the National Wilms' Tumor Study Group. Med Pediatr Oncol 26:75-80, 1996
43. Green DM, Grigoriev YA, Nan B, et al: Congestive heart failure after treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 19:1926-1934, 2001
44. Rowland JH: Foreword: Looking beyond cure - Pediatric cancer as a model. J Pediatr Psychol 30:1-3, 2005
45. Robison LL, Mertens AC, Boice JD, et al: Study design and cohort characteristics of the Childhood Cancer Survivor Study: A multi-institutional collaborative project. Med Pediatr Oncol 38:229-239, 2002
46. Hudson MM, Mertens AC, Yasui Y, et al: Health status of adult long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. JAMA 290:1583-1592, 2003
47. Robison LL, Green DM, Hudson M, et al: Long-term outcomes of adult survivors of childhood cancer. Cancer 104:2557-2564, 2005
48. Oeffinger KC, Eshelman DA, Tomlinson GE, et al: Programs for adult survivors of childhood cancer. J Clin Oncol 16:2864-2867, 1998
49. Schidlow DV, Fiel SB: Life beyond pediatrics: Transition of chronically ill adolescents from pediatric to adult health care systems. Med Clin North Am 74:1113-1120, 1990
50. Blum RW: Transition to adult health care: Setting the stage. J Adolesc Health 17:3-5, 1995
51. Hobbie WL, Ogle S: Transitional care for young adult survivors of childhood cancer. Semin Oncol Nurs 17:268-273, 2001
52. Friedman DL, Freyer DR, Levitt GA: Models of care for survivors of childhood cancer. Pediatr Blood Cancer 46:159-168, 2006
53. Landier W, Bhatia S, Eshelman DA, et al: Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22:4979-4990, 2004
54. Kadan-Lottick NS, Robison LL, Gurney JG, et al: Childhood cancer survivors' knowledge about tlieir past diagnosis and treatment: Childhood Cander Survivor Study. JAMA 287:1832-1839, 2002
55. Jacobs LA, Hobbie WL: The Living Well After Cancer Program: An advanced practice model of care. ONF Leadership Professional Development 29:637-638, 2002
56. Oeffinger KC, Mertens AC, Sklar CA, et al: Incidence and severity of chronic health conditions in adult survivors of pediatric cancer: A report from fhe Childhood Cancer Survivor Study. N Engl J Med 355:1572-1582, 2006
57. D'Angio GJ, Breslow N, Beckwith JB, et al: Treatment of Wilms' tumor: Results of the Third National Wilms' Tumor Study. Cancer 64:349-360, 1989
58. Tubergen DG, Gilchrist GS, O'Brien RT, et al: Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: A Children's Cancer Group phase III trial. J Clin Oncol 11:527-537, 1993
59. Pui CH, Ribeiro RC, Hancock ML, et al: Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 325:1682-1687, 1991
60. Schellong G, Potter R, Bramswig J, et al: High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: The German-Austrian multicenter trial DAL-HD-90 - The German-Austrian Pediatric Hodgkin's Disease Study Group. J Clin Oncol 17:3736-3744, 1999
61. Smith MA, Rubinstein L, Anderson JR, et al: Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol 17:569-577, 1999
62. Hobbie WL, Stuber M, Meeske K, et al: Symptoms of posttraumatic stress in young adult survivors of childhood cancer. J Clin Oncol 18:4060-4066, 2000
63. Silber JH, Cnaan A, Clark BJ, et al: Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol 22:820-828, 2004
64. Moller TR, Garwicz S, Barlow L, et al: Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: A population-based study in the Nordic countries. J Clin Oncol 19:3173-3181, 2001
65. Mertens AC, Yasui Y, Neglia JP, et al: Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study. J Clin Oncol 19:3163-3172, 2001
66. Mertens AC, Walls RS, Taylor L, et al: Characteristics of childhood cancer survivors predicted their successful tracing. J Clin Epidemiol 57:933-944, 2004
67. Oeffinger KC, Wallace WH: Barriers to follow-up care of survivors in the United States and the United Kingdom. Pediatr Blood Cancer 46:135-142, 2006
68. Bhatia S, Meadows AT: Long-term follow-up of childhood cancer survivors: Future directions for clinical care and research. Pediatr Blood Cancer 46:143-148, 2006